scanX
Home
Procter & Gamble Health

Procter & Gamble Health

5,101.20
-22.50
(-0.44%)
Market Cap (₹ Cr.)
₹8,505
52 Week High
5,642.85
Book Value
₹
52 Week Low
4,636.55
PE Ratio
39.52
PB Ratio
15.80
PE for Sector
50.94
PB for Sector
90.92
ROE
30.56 %
ROCE
103.24 %
Dividend Yield
1.20 %
EPS
₹128.93
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Multinational
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
10.68 %
Net Income Growth
19.19 %
Cash Flow Change
39.22 %
ROE
-2.14 %
ROCE
13.93 %
EBITDA Margin (Avg.)
10.36 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
204
252
262
244
221
273
273
258
236
178
222
217
219
242
243
913
249
251
232
243
238
212
271
246
222
288
276
283
270
299
301
315
326
307
311
315
255
286
Expenses
186
221
237
212
204
232
223
226
206
150
169
174
174
169
168
189
181
179
175
188
169
148
186
151
188
237
195
216
199
237
207
201
241
256
216
208
185
256
EBITDA
18
32
25
32
17
41
51
32
29
28
53
42
44
72
75
724
68
72
57
55
69
64
85
94
34
51
81
67
71
62
94
113
85
51
95
107
70
30
Operating Profit %
2 %
8 %
4 %
8 %
3 %
11 %
15 %
10 %
10 %
9 %
18 %
2 %
12 %
23 %
26 %
8 %
22 %
23 %
22 %
21 %
26 %
26 %
30 %
37 %
14 %
17 %
29 %
22 %
26 %
20 %
31 %
35 %
25 %
15 %
29 %
33 %
27 %
10 %
Depreciation
4
5
5
8
6
6
6
6
6
5
5
5
7
5
4
5
4
5
4
4
4
8
7
8
8
7
7
7
6
7
7
8
6
7
6
7
7
7
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
13
26
20
23
11
34
44
26
23
23
48
37
37
67
71
720
63
68
53
51
65
56
77
86
26
44
74
60
65
55
87
105
79
44
88
100
63
23
Tax
4
9
8
9
2
10
19
10
11
6
12
17
13
16
19
2
28
22
8
14
15
8
19
19
10
13
19
15
14
12
22
30
23
15
22
30
16
13
Net Profit
10
17
13
15
8
23
29
19
15
20
32
27
23
48
52
715
41
44
36
38
46
49
59
68
16
34
55
45
51
41
64
77
59
30
66
72
47
17
EPS in ₹
5.80
10.16
7.54
8.78
5.06
13.72
17.17
11.71
8.93
12.12
19.09
16.43
13.68
29.10
31.53
430.94
24.52
26.60
21.50
23.02
28.00
29.40
35.70
40.90
9.50
20.40
33.40
27.00
30.80
24.81
38.30
46.30
35.66
17.96
39.50
43.40
28.00
9.50
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2020
2021
2022
2023
Total Assets
784
879
991
1,759
1,176
986
888
1,101
Fixed Assets
132
111
115
104
101
104
112
144
Current Assets
572
636
752
1,534
954
727
608
796
Capital Work in Progress
7
30
9
17
21
39
41
32
Investments
42
28
70
0
0
0
0
0
Other Assets
603
711
797
1,639
1,053
843
736
925
Total Liabilities
192
215
258
219
269
282
272
350
Current Liabilities
165
186
225
193
227
239
232
304
Non Current Liabilities
27
29
33
27
42
43
40
46
Total Equity
592
664
733
1,540
906
704
616
751
Reserve & Surplus
575
647
717
1,524
890
687
600
734
Share Capital
17
17
17
17
17
17
17
17
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2020
2021
2022
2023
Net Cash Flow
4
17
-16
1,109
-483
-172
-145
116
Investing Activities
-68
-75
-48
1,270
165
-32
-26
-22
Operating Activities
83
107
54
-130
235
247
170
236
Financing Activities
-12
-15
-22
-30
-883
-387
-289
-98
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
FIIs
6.71 %
6.45 %
5.88 %
5.97 %
6.57 %
6.47 %
6.05 %
6.33 %
6.72 %
7.15 %
7.38 %
7.59 %
6.24 %
6.40 %
DIIs
11.48 %
11.81 %
8.37 %
8.53 %
7.90 %
8.07 %
12.62 %
12.43 %
12.32 %
12.30 %
12.31 %
12.67 %
13.73 %
14.56 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.00 %
29.93 %
33.94 %
33.69 %
33.71 %
33.64 %
29.51 %
29.42 %
29.15 %
28.74 %
28.49 %
27.92 %
28.21 %
27.23 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Abbott
27,971.60 61,353.43 49.52 6,097.18 10.80 1,201 13.01 37.10
GlaxoSmithKline Pharmaceuticals
2,698.35 47,433.69 61.58 3,576.30 6.68 590 37.87 39.33
Pfizer
5,667.30 27,100.04 44.97 2,373.68 -6.02 551 61.14 36.46
AstraZeneca Pharma
6,716.25 16,674.13 127.28 1,330.33 29.27 162 -121.89 47.38
Sanofi
7,177.55 16,544.18 33.68 2,916.40 - 603 -16.03 58.99
Sanofi Consumer Healthcare
5,349.95 11,871.48 - 0.00 - 0 -69.11 -
Procter & Gamble Health
5,101.20 8,505.01 39.52 1,248.01 10.68 229 -43.73 41.12

Corporate Action

Technical Indicators

RSI(14)
Neutral
41.12
ATR(14)
Less Volatile
112.15
STOCH(9,6)
Oversold
12.69
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-22.07
ADX(14)
Weak Trend
12.03
UO(9)
Bearish
34.72
ROC(12)
Downtrend And Accelerating
-2.90
WillR(14)
Oversold
-87.42
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.